Pharmacologic Treatment of Personality Disorders

Professional Psychology: Research and Practice

Volumn 33, Issue 1, 2002, Pages 104-107

  Rivas Vazquez, Rafael A ^a,b   Blais, Mark A ^c,d  

^a Neurologic Center of South Florida   (United States)

^b MIAMI RESEARCH ASSOCIATES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542403991     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.33.1.104     Document Type: Review

References (29)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., rev.). Washington, DC: Author.
2. American Psychiatric Association. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 158, 1-52.
3. Bender, D. S., Dolan, R. T., Skodol, A. E., Sanislow, C. A., Dyck, I. R., McGlashan, T. H., et al. (2001). Treatment utilization by patients with personality disorders. American Journal of Psychiatry, 158, 295-302.
4. Benedetti, F., Sforzini, L., Colombo, C., Maffei, C., & Smeraldi, E. (1998). Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry, 59, 103-107.
5. Bohus, M. J., Landwehrmeyer, G. B., Stiglmayr, C. E., Limberger, M. F., Bohme, R., & Schmahl, C. G. (1999). Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: An open-label trial. Journal of Clinical Psychiatry, 60, 598-603.
6. Byne, W., Buchsbaum, M. S., Kemether, E., Hazlett, E. A., Shinwari, A., Mitropoulou, V., & Siever, L. J. (2001). Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Archives of General Psychiatry, 58, 133-140.
7. Cadenhead, K. S., Light, G. A., Geyer, M. A., & Braff, D. L. (2000). Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. American Journal of Psychiatry, 157, 55-59.
8. Chengappa, K. N., Ebeling, T., Kang, J. S., Levine, J., & Parepally, H. (1999). Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry, 60, 477-484.
9. Cloninger, C. R., & Svrakic, D. M. (2000). Personality disorders. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 1723-1764). Philadelphia: Lippincott/Williams & Wilkins.
10. Coccaro, E. F. (1998). Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. Journal of Clinical Psychiatry, 59(Suppl. 1), 30-35.
11. Driessen, M., Herrmann, J., Stahl, K., Zwaan, M., Meier, S., Hill, A., et al. (2000). Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry, 57, 1115-1122.
12. Gunderson, J. G. (2001). Borderline personality disorder: A clinical guide. Washington, DC: American Psychiatric Publishing.
13. Gurvits, I. G., Koenigsberg, H. W., & Siever, L. J. (2000). Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatric Clinics of North America, 23, 27-40.
14. Hirose, S. (2001). Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone. Psychiatry & Clinical Neurosciences, 55, 161-162.
15. Hollander, E. H., Allen, A., Prieto Lopez, R., Bienstock, C. A., Grossman, R., Siever, L. J., et al. (2001). A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry, 62, 199-203.
16. Hough, D. W. (2001). Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder. Journal of Clinical Psychiatry, 62, 296-297.
17. Janicak, P. G., Davis, J. M., Preskorn, S. H., & Ayd, F. J. (1997). Principles and practice of psychopharmacotherapy. Baltimore: Williams & Wilkins.
18. Kapfhammer, H.-P., & Hippius, H. (1998). Pharmacotherapy in personality disorders. Journal of Personality Disorders, 12, 277-288.
19. Kavoussi, R. J., & Coccaro, E. F. (1998). Divalproex sodium for impulsive aggressive behavior in patients with borderline personality disorder. Journal of Clinical Psychiatry, 59, 676-680.
20. Kirrane, R. M., & Siever, L. J. (2000). New perspectives on schizotypal personality disorder. Current Psychiatry Reports, 2, 62-66.
21. Leyton, M., Okazawa, H., Diksic, M., Paris, J., Rosa, P., Mzengeza, S., et al. (2001). Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. American Journal of Psychiatry, 158, 775-782.
22. Markovitz, P. J., & Wagner, S. C. (1995). Venlafaxine in the treatment of borderline personality disorder. Psychopharmacology Bulletin, 31, 773-777.
23. McGee, M. D. (1997). Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone [Letter]. Journal of Clinical Psychiatry, 58, 32-33.
24. Raine, A., Lencz, T., Birhle, S., LaCasse, L., & Colletti, P. (2000). Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Archives of General Psychiatry, 57, 119-127.
25. Schulz, S. C., Camlin, K. L., Berry, S. A., & Jesberger, J. A. (1999). Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biological Psychiatry, 46, 1429-1435.
26. Siever, L. J., & Davis, K. L. (1991). A psychobiological perspective on personality disorders. American Journal of Psychiatry, 148, 1647-1568.
27. Soloff, P. H. (2000). Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America, 23, 169-192.
28. Townsend, M. H., Cambre, K. M., & Barbee, J. G. (2001). Treatment borderline personality disorder with mood instability with divalproex sodium: A series of ten cases. Journal of Clinical Psychopharmacology, 21, 249-251.
29. Vilkin, M. I. (1964). Comparative chemotherapeutic trial in treatment of chronic borderline patients. American Journal of Psychiatry, 120, 1004.